Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.

History

Cardio Diagnostics was founded in 2003 as a medical research and development company specializing in cardiology. By 2009, the company had developed and released its first device, the C-Search, a continuous ECG monitoring device, which has since been released to multiple markets around the world. Today, Cardio Diagnostics is dedicated to providing the highest quality products and services to the cardiology community.

Mission

Our mission at Cardio Diagnostics is to provide the highest quality medical devices, services and support to cardiologists and heart veterinarians, while upholding the highest clinical and ethical standards.

Vision

At Cardio Diagnostics, our vision is to be the primary provider of innovative, patient-centric cardiology products and deliver unmatched value to our customers.

Key Team

Khullani Abdullah (VP of Revenue & Strategy)

Recognition and Awards

Cardio Diagnostics has been recognized for its innovation, customer service and dedication to developing medical devices for cardiologists. The company has been the recipient of multiple awards, including the Technology Innovation Award from the Cardiology Society of America, the Rising Star Award from the American Medical Association, and the Medical Device Innovation Excellence Award from the National Association of Medical Devices Manufacturers.

References

https://in.investing.com/equities/mana-capital-acquisition

https://finance.yahoo.com/quote/CDIOW/profile?p=CDIOW

https://www.crunchbase.com/organization/cardio-diagnostics

https://cardiodiagnosticsinc.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Leadership team

Dr. Meeshanthini Dogan Ph.D. (CEO & Director)

Ms. Elisa Michael Luqman J.D., M.B.A. (CFO & Director)

Dr. Robert A. Philibert M.D., Ph.D. (Chief Medical Officer & Director)

Products/ Services

Biotechnology, Health Care, Medical

Number of Employees

0 - 50

Headquarters

Chicago, Illinois, United States

Established

2017

Company Registration

SEC CIK number: 0001870144

Traded as

NASDAQ:CDIO

Social Media

URL

https://cardiodiagnosticsinc.com

Last updated: Tue Feb 25 2025

We value your privacy

Cardio Diagnostics

Table of content

Summary